Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    19481407 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
Conditions: Critical Limb Ischemia;   Peripheral Artery Disease
Interventions: Dietary Supplement: SPM Emulsion, Dose-modality;   Dietary Supplement: SPM Emulsion;   Other: Placebo
2 Completed Optical Imaging Measurement of Intravascular Solution Efficacy Trial
Condition: Peripheral Artery Disease
Intervention: Procedure: iOCT

Indicates status has not been verified in more than two years